High-throughput X-ray crystallography for drug discovery

Area of Science:

• Structural biology
• Drug discovery
• Medicinal chemistry

Background:

• Three-dimensional protein structures are crucial for drug discovery but historically limited to lead optimization due to technical challenges.
• Nuclear magnetic resonance (NMR) is used for detecting ligand binding and mapping binding sites.
• X-ray crystallography offers precise definition of ligand-binding sites.

Purpose of the Study:

• To explore the extended application of protein structure determination in lead discovery.
• To highlight the role of X-ray crystallography in high-throughput screening and fragment-based drug design.

Main Methods:

• Utilizing X-ray crystallography for high-throughput screening of molecular fragments binding to protein targets.
• Employing X-ray crystallography to precisely define binding sites of identified fragments.
• Applying structure-activity relationships (SAR) by NMR to detect ligand binding.

Main Results:

• X-ray crystallography can be rapidly applied to screen for molecular fragments that bind protein targets.
• Precise binding site information is obtained through X-ray crystallography.
• This structural information guides the optimization of fragments into potential drug leads.

Conclusions:

• Protein structure determination, particularly X-ray crystallography, is increasingly vital for early-stage drug discovery.
• High-throughput X-ray crystallography enables efficient fragment screening and lead generation.
• Structural insights accelerate the development of novel drug candidates.